TheEdgeResearch
Home / Stocks / LXGTF

Lexington Biosciences, Inc. (LXGTF)

OTC Healthcare Medical - Specialties
$0.00 ▲ +0.00%
Market Cap
$379
Sector
Healthcare
Industry
Medical - Specialties
Beta
-5.44
52-Wk Range
0.00001-0.0002
CEO
Donald Arthur McInnes
Country
CA
Currency
USD

Lexington Biosciences, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $379. On trailing twelve-month figures it carries a trailing P/E of -0.02, a net margin of 0.0%. Its beta of -5.44 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.02
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
0.00
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
543
IPO date
2017-07-19
Headquarters
Vancouver, BC, CA
About Lexington Biosciences, Inc.

Registered Plan Private Investments Inc. operates as a private investment platform company. Its platform allows investors to use their registered plans, including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans at their direction to invest in private companies. The company was formerly known as Lexington Biosciences, Inc. and changed its name to Registered Plan Private Investments Inc. in May 2020. The company was incorporated in 2016 and is headquartered in Vancouver, Canada.

Comparable companies

Lexington Biosciences, Inc. is most often compared with the following Healthcare names:

ACAIAHFDBFHJDMCDEZTDMDLMNVPLFPHCFFSPOISYSX
More research on LXGTF
LXGTF technical analysis LXGTF TheEdge Score Compare against peers
Open full interactive analysis & DCF →